Schellinger P D, Fiebach J B
Neurologische Klinik, Universitätsklinikum Heidelberg.
Radiologe. 2004 Apr;44(4):380-8. doi: 10.1007/s00117-003-1003-7.
Thrombolysis is the treatment of choice for acute stroke within 3 h after symptom onset. Treatment beyond the 3 h time window has not been shown to be effective in any single trial, however, metaanalyses suggest a somewhat less but still significant effect within 3 to 6 h after stroke. It seems reasonable to apply improved selection criteria that allow to differentiate the patients with a relevant indication for thrombolytic therapy from those who have not. While stroke MRI seems to be the upcoming standard, due to its low availability the need for an improved CT-based patient selection is evident.
The present literature on imaging in stroke has been thoroughly reviewed. The diagnostic strengths and weaknesses of conventional CT, CT angiography (CTA), CTA source image analysis (CTA-SI) and perfusion CT (PCT) for an acute diagnostic stroke workup are critically reviewed in this article. The authors present their view about a comprehensive diagnostic approach to acute stroke in accordance to stroke MRI findings, which allows to challenge the rigid therapeutic time window and improve patient management.
Information about the presence or absence of ICH by non contrast CT and vessel occlusion by means of CTA is deemed obligatory before rt-PA is given in the 3-6 hour time window. Clear demarcation of an early hypodensity exceeding 1/3 of the MCA territory on NCCT or CTA-SI should preclude thrombolytic therapy. The irreversibly damaged infarct core and the ischemic but still viable thus salvageable tissue at risk of infarction as seen on CT/CTA/CTA-SI/PCT should be obtained before thrombolysis is initiated within 3-6 hours. Once these advanced techniques are used, the therapeutic time window can be extended with acceptable safety. However, comprehensive informed consent is mandatory, especially when thrombolytic therapy is considered beyond established time windows.
溶栓是症状出现后3小时内急性卒中的首选治疗方法。然而,在任何单一试验中,超过3小时时间窗的治疗均未显示有效,但荟萃分析表明,卒中后3至6小时内虽效果稍差但仍有显著疗效。应用改进的选择标准,以区分有溶栓治疗相关指征的患者与无此指征的患者,似乎是合理的。虽然卒中磁共振成像(MRI)似乎即将成为标准,但由于其可用性低,显然需要改进基于CT的患者选择方法。
对目前有关卒中影像学的文献进行了全面回顾。本文对传统CT、CT血管造影(CTA)、CTA源图像分析(CTA-SI)和灌注CT(PCT)在急性卒中诊断检查中的诊断优缺点进行了批判性综述。作者根据卒中MRI结果,提出了关于急性卒中综合诊断方法的观点,这有助于挑战严格的治疗时间窗并改善患者管理。
在3至6小时时间窗内给予rt-PA之前,通过非增强CT了解有无脑出血以及通过CTA了解血管闭塞情况被认为是必要的。在NCCT或CTA-SI上,早期低密度区超过大脑中动脉(MCA)区域的1/3,应排除溶栓治疗。在3至6小时内开始溶栓之前,应通过CT/CTA/CTA-SI/PCT确定不可逆损伤的梗死核心以及缺血但仍存活因而有梗死风险可挽救的组织。一旦使用这些先进技术,治疗时间窗可以在可接受的安全性下延长。然而,必须获得全面的知情同意,特别是在考虑超出既定时间窗的溶栓治疗时。